Mullis Brian H, Gudeman Andrew S, Borrelli Joseph, Crist Brett D, Lee Mark A, Evans Andrew R
Department of Orthopaedic Surgery, Indiana University School of Medicine, Indianapolis, IN.
Department of Orthopaedic Surgery and Sports Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL.
OTA Int. 2021 Apr 15;4(2 Suppl). doi: 10.1097/OI9.0000000000000100. eCollection 2021 Apr.
Fracture healing is a complex cascade of cellular and molecular processes. These processes require the appropriate cellular and molecular environment to ensure the restoration of skeletal stability and resolution of inflammation. In order for fracture healing to occur, the necessary building blocks for bone metabolism and synthesis must be supplied through proper nutrition. Pharmacologic therapies aimed at modulating the inflammatory response to fractures have the potential to interfere with the synthesis of molecules needed for the production of bone. Infection can interfere with, and even prevent normal fracture healing from occurring. Cellular and genetic treatment strategies are actively being developed to target deficiencies, and bridge gaps that can influence how fractures heal. Evolving technologies, including nutritional supplementation, pharmacotherapies, antibiotics, surgical techniques, as well as genetic and cellular therapies, have the potential to enhance, optimize, and even revolutionize the process of fracture healing.
骨折愈合是一个复杂的细胞和分子过程级联反应。这些过程需要合适的细胞和分子环境,以确保骨骼稳定性的恢复和炎症的消退。为了实现骨折愈合,必须通过适当的营养供应骨代谢和合成所需的必要组成部分。旨在调节对骨折的炎症反应的药物治疗有可能干扰骨生成所需分子的合成。感染会干扰甚至阻止正常骨折愈合的发生。目前正在积极开发细胞和基因治疗策略,以针对可能影响骨折愈合方式的缺陷并弥合差距。不断发展的技术,包括营养补充、药物治疗、抗生素、手术技术以及基因和细胞疗法,有可能增强、优化甚至彻底改变骨折愈合过程。